KSP-1007   Click here for help

GtoPdb Ligand ID: 13547

Compound class: Synthetic organic
Comment: KSP-1007 is a bicyclic boronic acid β-lactamase inhibitor (BLI), with broad-spectrum activity against both serine and metallo-β-lactamases, discovered through a collaboration between the Kitasato Institute (Tokyo, Japan) and Sumitomo Pharma (Osaka, Japan) [1]. KSP-1007, in combination with meropenem, is under clinical development for the treatment of infections caused by carbapenem-resistant bacterial infections.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 4
Rotatable bonds 6
Topological polar surface area 146.71
Molecular weight 386.17
XLogP -1.14
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C2CCB(O)OC2=C(C(=C1)OC3CN(C3)C(=O)[C@@H](C4=CNC=N4)N)C(=O)O
Isomeric SMILES C1=CC(=C(C2=C1CCB(O)O2)C(=O)O)OC3CN(C3)C(=O)[C@@H](C4=CNC=N4)N
InChI InChI=1S/C17H19BN4O6/c19-14(11-5-20-8-21-11)16(23)22-6-10(7-22)27-12-2-1-9-3-4-18(26)28-15(9)13(12)17(24)25/h1-2,5,8,10,14,26H,3-4,6-7,19H2,(H,20,21)(H,24,25)/t14-/m1/s1
InChI Key CAHUDGVGUAJGGS-CQSZACIVSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
KSP-1007 displays potent activity against all classes of β-lactamase enzymes, including class B (Kiapp in the range 31.6 nM to 1.21 μM) and the class D (OXA) enzymes of Acinetobacter baumannii (Kiapp of 0.621-5.78 nM) [1]. The same study found that KSP-1007 potentiates the in vitro and in vivo activity of meropenem against carbapenemase-producing Enterobacterales, A. baumannii, and Pseudomonas aeruginosa.